Minisymposium der SCS, SCS / Division of Medicinal Chemistry
Start Date | 07.06.2012 - 14:00 |
Event End | 07.06.2012 - 14:00 |
Location | Universität Basel, Organische Chemie |
Confirmed Speakers:
- Neil Pegg, Cellcentric Cambridge, UK, «Epigenetics: Providing new targets for drug discovery»
- Andre Fischer, University og Goetttingen / Max Planck Institute for Experimental Medicine, Germany, «Epigenetic mechanisms in neurodegenerative diseases»
- Chun-Wa Chung, Inhibitors of epigenetic bromodomains extend the druggable genome, «Exploiting epigenetic bromodomains: From phenotypic to fragment based drug discovery»
- Michael G. Schultz, Novartis Institute for Biomedical Research, Cambridge USA, «HDAC Inhibitors: Not for the faint of heart - or are they?»
Contact: